Pharma News

6 September 2024

Alembic Pharmaceuticals announces USFDA Final Approval for Albendazole Tablets USP, 200 mg

Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA. Alembic is one of the leaders in branded generics in India.

6 September 2024

Strides receive USFDA approval for Theophylline Extended-Release Tablets, 300 mg and 450 mg

Strides Pharma Science Limited announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for the generic version of Theophylline Extended-Release Tablets, 300 mg and 450 mg, from the United States Food & Drug Administration

6 September 2024

Sun Pharma and Moebius Medical Announce Fast Track Designation Granted for MM-II for the Treatment of Osteoarthritis Knee Pain

Sun Pharma and Israel-based Moebius Medical Limited announced that the U.S. Food and Drug Administration has granted Fast Track designation to MM-II Large Liposomes of DPPC and DMPC for the treatment of osteoarthritis knee pain. Planning for confirmatory Phase 3 clinical trials for MM- II is underway.

3 September 2024

Dr. Akram Ahmad, Founder of Academically Global, Honored with BW Healthcare World 40 Under 40 Award 2024

Dr. Akram Ahmad, founder of Academically Global, has been recognized as one of the recipients of the prestigious BW HealthcareWorld 40 Under 40 Awards 2024. The awards ceremony took place on August 31, 2024, at The Imperial Hotel, Janpath, New Delhi. This accolade celebrates the dynamic young leaders shaping the future of healthcare in India.

2 September 2024

Mechanisms of how morphine relieves pain mapped out

In a study published in Science, researchers at Karolinska Institutet describe the neural processes behind how morphine relieves pain. This is valuable knowledge because the drug has such serious side effects.

Morphine is a powerful painkiller that belongs to the group of opioids. It blocks signals in the pain pathways and also increases feelings of pleasure. Morphine acts on several central and peripheral pain pathways in the body, but the neural processes behind the pain relief have not previously been fully understood.

2 September 2024

New findings on TB could change how we treat inflammatory disorders

Tuberculosis is a confounding scourge. Its the leading cause of death from infectious disease in the world, and yet its estimated that those deaths represent perhaps 5% of infections with Mycobacterium tuberculosis.

29 August 2024

Now Graduation mandatory for recruitment as CGHS Pharmacist

The Central Government has released new rules for the recruitment of pharmacists in the Central Government Health Scheme, CGHS. According to the new recruitment rules published in the Government of India Gazette Notification, the minimum educational qualification for recruitment to the post of pharmacist in CGHS has been set to a graduation degree.

28 August 2024

Gut Bacteria Composition Influences Rotavirus Vaccine Efficacy

Certain types of gut bacteria can hinder the efficacy of the rotavirus vaccine, according to researchers in the Institute for Biomedical Sciences at Georgia State University.

24 August 2024

Fasenra approved in China for the treatment of severe eosinophilic asthma

AstraZeneca Fasenra benralizumab has been approved in China by the country National Medical Products Association NMPA for the maintenance treatment of patients 12 years of age and older with severe eosinophilic asthma.

22 August 2024

Eugia Pharma receives warning letter from FDA

Eugia Pharma receives a warning letter from FDA which summarizes significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals.

U.S. Food and Drug Administration (FDA) inspected a drug manufacturing facility of Eugia Pharma Specialities Limited (Unit III), at Patancheru (Mandal), Sangareddy, Hyderabad, Telangana, from January 22 to February 2, 2024. It is a wholly owned subsidiary of the Aurobindo Pharma.

Search

Alembic Pharmaceuticals announces USFDA Final Approval for Albendazole Tablets USP, 200 mg

RECOMMENDED POSTS

Subscribe with us

Jobs by Category